BYSI BeyondSpring, Inc. - Ordinary Shares
$0.72
价格 · 八月 19, 2026
截至...的财报数据 八月 14, 2026
BYSI 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.72
市值
—
P/E (TTM)
—
每股收益 (TTM)
—
营收 (TTM)
$0
股息收益率
—
ROE
3.1%
负债/权益
—
52周区间
$1 – $2
BYSI 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2023-12-31
→
2025-12-31
EPS
—
自由现金流
$-20M
2024-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BYSI
同行中位数
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BYSI
同行中位数
ROA
-3.3%
-78.1%
ROE
3.1%
-228.7%
ROIC
28.1%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BYSI
同行中位数
Current Ratio (流动比率)
1.5
1.2
Quick Ratio (速动比率)
0.9
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BYSI
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BYSI
同行中位数
BYSI 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 3 42.9%
- 买入 3 42.9%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.03%
下次报告
九月 04, 2026
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.05 | — | — |
| 2021年12月31日 | $-0.24 | $-0.27 | 0.03% |
| 2021年9月30日 | $-0.47 | $-0.38 | -0.09% |
| 2021年6月30日 | $-0.49 | $-0.33 | -0.16% |
| 2021年3月31日 | $-0.44 | $-0.55 | 0.11% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
| LITS | $16M | -1.0 | 33.8% | — | -81.7% | — |
| GRML | — | — | — | — | -104.9% | — |
| GRDX | $20M | -1.1 | — | -17634.4% | -68.6% | -1813.6% |
| DYAI | — | -4.1 | -11.6% | — | — | — |
| ATOS | $5M | -0.1 | — | — | -71.7% | — |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 10
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | |
| R&D Expense | $4M | $3M | $7M | |
| SG&A Expense | $5M | $6M | $8M | |
| Operating Income | $-9M | $-9M | $-15M | |
| Interest Income | $78.0K | $59.0K | $322.0K | |
| Pretax Income | $-9M | $-9M | $-14M | |
| Income Tax | $90.0K | $96.0K | $-92.0K | |
| Net Income | $-1M | $-11M | $-21M | |
| EPS (Basic) | $-0.02 | $-0.28 | $-0.54 | |
| EBITDA | $-9M | $-9M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $5M | |
| Short-term Investments | $5M | $0 | · | |
| Prepaid Expense | $71.0K | $68.0K | $168.0K | |
| Current Assets | $21M | $29M | $18M | |
| PP&E (Net) | $166.0K | $239.0K | $317.0K | |
| PP&E (Gross) | $807.0K | $793.0K | $799.0K | |
| Accum. Depreciation | $641.0K | $554.0K | $482.0K | |
| Other Non-current Assets | $224.0K | $213.0K | $123.0K | |
| Total Assets | $26M | $34M | $25M | |
| Accounts Payable | $363.0K | $295.0K | $561.0K | |
| Accrued Liabilities | $938.0K | $840.0K | $2M | |
| Current Liabilities | $14M | $11M | $8M | |
| Capital Leases | $0 | $307.0K | $589.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | |
| Total Liabilities | $50M | $49M | $48M | |
| Common Stock | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $376M | $373M | $369M | |
| Retained Earnings | $-408M | $-407M | $-396M | |
| AOCI | $602.0K | $1M | $894.0K | |
| Stockholders' Equity | $-32M | $-33M | $-27M | |
| Liabilities + Equity | $26M | $34M | $25M | |
| Shares Outstanding | 41,122,320 | 40,316,320 | 39,029,163 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $722.0K | $2M | $770.0K | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-20M | $-16M | $-16M | |
| CapEx | $50.0K | $224.0K | $100.0K | |
| Investing Cash Flow | $11M | $-12M | $-100.0K | |
| Stock Issued | $2M | $3M | $0 | |
| Net Stock Activity | $2M | $3M | · | |
| Financing Cash Flow | $5M | $27M | $4.0K | |
| Net Change in Cash | $-4M | $-2M | $-17M | |
| Taxes Paid | $2.0K | $7.0K | $36.0K | |
| Free Cash Flow | $-20M | $-17M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -3.3% | -37.6% | · | |
| ROE | 3.1% | 37.3% | · | |
| ROIC | 28.1% | 26.3% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 1.5 | 2.6 | · | |
| Quick Ratio | 0.9 | 0.3 | · |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
估值 (TTM) 6
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | |
| Net Income TTM | $-1M | $-11M | · | |
| Market Cap | · | $66M | · | |
| P/B | · | -2.0 | · | |
| P / Cash Flow | · | -4.0 | · | |
| P / FCF | · | -3.9 | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $973.0K | $1M | $1M | $1M | $1M | $874.0K | $472.0K | $622.0K | |
| SG&A Expense | $758.0K | $1M | $1M | $751.0K | $947.0K | $2M | $1M | $2M | |
| Operating Income | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Interest Income | $4.0K | $8.0K | $14.0K | $19.0K | $28.0K | $17.0K | $4.0K | $15.0K | |
| Pretax Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Income Tax | $100.0K | $192.0K | $22.0K | $26.0K | $22.0K | $20.0K | $96.0K | $0 | |
| Net Income | $-849.0K | $-2M | $-2M | $-2M | $-2M | $4M | $-2M | $-2M | |
| EPS (Basic) | $-0.02 | $-0.05 | $-0.05 | $-0.04 | $-0.04 | $0.11 | $-0.05 | $-0.05 | |
| EPS (Diluted) | · | · | · | $0.16 | $-0.10 | · | · | · | |
| Shares (Basic) | 41,119,820 | 41,119,803 | · | 40,317,266 | 40,316,320 | 40,316,320 | · | 40,300,350 | |
| EBITDA | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | · |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $8M | $12M | $10M | $7M | $3M | · | |
| Short-term Investments | $4M | $4M | $5M | $141.0K | · | $2M | $0 | · | |
| Prepaid Expense | $273.0K | $181.0K | $71.0K | $131.0K | $200.0K | $90.0K | $68.0K | · | |
| Current Assets | $10M | $14M | $21M | $24M | $26M | $32M | $29M | · | |
| PP&E (Net) | $138.0K | $152.0K | $166.0K | $184.0K | $202.0K | $221.0K | $239.0K | · | |
| PP&E (Gross) | $817.0K | $812.0K | $807.0K | $803.0K | $800.0K | $796.0K | $793.0K | · | |
| Accum. Depreciation | $679.0K | $660.0K | $641.0K | $619.0K | $598.0K | $575.0K | $554.0K | · | |
| Other Non-current Assets | $128.0K | $126.0K | $224.0K | $219.0K | $216.0K | $215.0K | $213.0K | · | |
| Total Assets | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Accounts Payable | $790.0K | $646.0K | $363.0K | $304.0K | $266.0K | $358.0K | $295.0K | · | |
| Accrued Liabilities | $1M | $1M | $938.0K | $990.0K | $926.0K | $909.0K | $840.0K | · | |
| Current Liabilities | $14M | $12M | $14M | $13M | $12M | $13M | $11M | · | |
| Capital Leases | · | · | $0 | $93.0K | $170.0K | $246.0K | $307.0K | · | |
| Other Non-current Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | |
| Total Liabilities | $51M | $49M | $50M | $49M | $49M | $50M | $49M | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $376M | $376M | $376M | $374M | $374M | $373M | $373M | · | |
| Retained Earnings | $-411M | $-411M | $-408M | $-406M | $-405M | $-403M | $-407M | · | |
| AOCI | $55.0K | $360.0K | $602.0K | $913.0K | $1M | $1M | $1M | · | |
| Stockholders' Equity | $-36M | $-34M | $-32M | $-32M | $-30M | $-28M | $-33M | · | |
| Liabilities + Equity | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Shares Outstanding | 41,119,820 | 41,119,820 | · | 40,322,320 | 40,322,320 | 40,316,320 | 40,316,320 | · |
现金流 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $575.0K | $461.0K | $167.0K | $166.0K | $145.0K | $244.0K | $399.0K | $827.0K | |
| Operating Cash Flow | $-4M | $-3M | $-6M | $-4M | $-6M | $-4M | $982.0K | $-5M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $50.0K | $27.0K | $197.0K | |
| Investing Cash Flow | $-5.0K | $4M | $-5M | $-1M | $11M | $6M | $-10M | $-2M | |
| Stock Issued | · | · | $2M | $0 | · | · | $0 | $0 | |
| Financing Cash Flow | $-74.0K | $-4M | $2M | $3M | $0 | $0 | $2M | $22M | |
| Net Change in Cash | $-4M | $-3M | $-9M | $-2M | $5M | $2M | $-7M | $15M | |
| Taxes Paid | $0 | $0 | $1.0K | $0 | $1.0K | $0 | $0 | $0 | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -3.7% | -7.8% | · | -10.4% | -11.6% | 24.1% | · | · | |
| ROE | 2.6% | 6.9% | · | 9.7% | 11.9% | -31.6% | · | · | |
| ROIC | 5.2% | 7.0% | · | 5.7% | 6.5% | 9.3% | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.1 | · | 1.9 | 2.2 | 2.5 | · | · | |
| Quick Ratio | 0.5 | 0.6 | · | 1.0 | 0.8 | 0.7 | · | · |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · |
估值 (TTM) 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | · | |
| Net Income TTM | $-6M | $-1M | · | $-1M | $-3M | $-5M | · | · | |
| Market Cap | $72M | $67M | · | $73M | $95M | $58M | · | · | |
| P/B | -2.0 | -2.0 | · | -2.3 | -3.1 | -2.0 | · | · | |
| P / Cash Flow | · | -20.6 | · | · | · | -13.8 | · | · | |
| P / FCF | · | -20.6 | · | · | · | -13.6 | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 收入 | $0 | $0 | $0 |
| 净收入 | $-1M | $-11M | $-21M |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 流动比率 | 1.5 | 2.6 | — |
| 速动比率 | 0.9 | 0.3 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 自由现金流 | $-20M | $-17M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 26 家申报者 · $9.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 8 (+6 与上一季度对比) | 1 (-7 与上一季度对比) | 3 (-1 与上一季度对比) | 4 (+2 与上一季度对比) | +790K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 8 位内幕人士 · 3 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Min Qiu | Chief Executive Officer | 2026年7月1日 A | — | 0 | 0 | $0 |
| Lan Huang | Chief Executive Officer | 2026年3月20日 G | 0 | 0 | 0 | $0 |
| Yingjuan June Lu | Chief Scientific Officer | 2026年4月1日 A | — | 0 | 0 | $0 |
| Jiangwen Majeti | 董事 | 2026年7月1日 A | — | 0 | 0 | $0 |
| Sihai Xu | 董事 | 2026年4月1日 A | — | 0 | 0 | $0 |
| Matthew Kirkby | 董事 | 2026年4月1日 A | — | 0 | 0 | $0 |
| Brendan Delaney | 董事 | 2026年4月1日 A | — | 0 | 0 | $0 |
| Patrick Fabbio | 董事 | 2026年4月1日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui ×2 申报 | 2020年12月8日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。